Session: Healthcare Leaders: Leveraging Data, Emerging MedTech & Collaboration to Meet the Needs of Underserved Communities
Healthcare products and medical technology are designed to diagnose, treat and support adherence to post-intervention care, ultimately changing the trajectory of one’s health and life experience. To increase affordability and accessibility, healthcare innovations must be backed by data to ensure products support every person. A cross-collaborative approach between clinical teams, researchers, regulatory and stakeholders is essential to satisfy and enhance patient outcomes.
With over 15 years in the healthcare industry, Arthi Chandran designs pathways to success for patients by working with the government, healthcare decision-makers and payers/providers to ensure technology is available to every patient. Using research and evidence-based insights, Arthi articulates the unmet needs of patients to help design services and products to support equity and access.
During the session, Arthi will expand upon how healthcare leaders can better collaborate to ensure data and research drive innovation and healthcare solutions. This will ultimately help create a more equitable healthcare ecosystem ensuring products are designed and available to every community.
- Solutions to ensure medical devices and products are designed to support the needs of every person.
- Cross-collaboration strategies with payers, providers, stakeholders, regulatory and the healthcare system to have a deeper engagement with clinical teams.
- Best practices to develop a deeper engagement with clinical teams to meet your stakeholder’s needs.
Arthi Chandran is the Divisional Vice President of Health Economics and Reimbursement for Abbott Medical Devices. In this capacity, Arthi leads a global team of researchers, and reimbursement specialists, responsible for ensuring that patients around the world have an equitable opportunity to experience the benefits of Abbott’s portfolio of life enhancing and lifesaving technologies.
Arthi has been a leader in both U.S. and Global roles and is focused on driving public health outcomes while delivering commercial growth in highly competitive markets. With over 15 years in the MedTech and Pharmaceutical industries, Arthi has been recognized for embedding a practice of value demonstration and communication through differentiated evidence generation strategies and accompanying economic tools.